These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 7669706)
1. Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias. Pott-Hoeck C; Hiddemann W Ann Oncol; 1995 May; 6(5):421-33. PubMed ID: 7669706 [TBL] [Abstract][Full Text] [Related]
3. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy]. Rucińska M; Machaczka M; Załuska A; Skotnicki AB Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885 [TBL] [Abstract][Full Text] [Related]
4. Present status of purine analogs in the therapy of chronic lymphocytic leukemias. Bergmann L Leukemia; 1997 Apr; 11 Suppl 2():S29-34. PubMed ID: 9178835 [TBL] [Abstract][Full Text] [Related]
5. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. Cheson BD; Vena DA; Barrett J; Freidlin B J Clin Oncol; 1999 Aug; 17(8):2454-60. PubMed ID: 10561309 [TBL] [Abstract][Full Text] [Related]
6. New prospects in the treatment of indolent lymphomas with purine analogues. Cheson BD Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S27-36. PubMed ID: 9672772 [TBL] [Abstract][Full Text] [Related]
7. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia. Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592 [No Abstract] [Full Text] [Related]
8. New purine analogues for the treatment of chronic B-cell malignancies. Gribbin TE Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757 [TBL] [Abstract][Full Text] [Related]
9. The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies. Saven A; Piro LD Cancer; 1993 Dec; 72(11 Suppl):3470-83. PubMed ID: 7902205 [TBL] [Abstract][Full Text] [Related]
10. Purine analogs in the treatment of chronic lymphocytic leukemia. Pott C; Hiddemann W Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834 [TBL] [Abstract][Full Text] [Related]
11. Purine nucleoside analogues in the treatment of myleoid leukemias. Robak T Leuk Lymphoma; 2003 Mar; 44(3):391-409. PubMed ID: 12688309 [TBL] [Abstract][Full Text] [Related]
12. Pentostatin and purine analogs for indolent lymphoid malignancies. Ho AD; Hensel M Future Oncol; 2006 Apr; 2(2):169-83. PubMed ID: 16563086 [TBL] [Abstract][Full Text] [Related]
13. Hairy cell leukemia and allied chronic lymphoid leukemias: current knowledge and new therapeutic options. Polliack A Leuk Lymphoma; 1997 Dec; 26 Suppl 1():41-51. PubMed ID: 9570679 [TBL] [Abstract][Full Text] [Related]
14. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies. Dearden CE; Matutes E; Catovsky D Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047 [TBL] [Abstract][Full Text] [Related]
15. New antimetabolites in the treatment of human malignancies. Cheson BD Semin Oncol; 1992 Dec; 19(6):695-706. PubMed ID: 1361080 [TBL] [Abstract][Full Text] [Related]
16. Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia. O'Brien S; Kantarjian H; Keating MJ Ann Oncol; 1996; 7 Suppl 6():S27-33. PubMed ID: 9010576 [TBL] [Abstract][Full Text] [Related]